Illumina Ventures is a leading genomics and precision health investment firm, dedicated to driving innovation and transforming human health. With a focus on building an ecosystem, they are at the forefront of translating investments into groundbreaking advancements. Their portfolio showcases cutting-edge companies making significant contributions to the field.

RedShiftBio, for instance, is revolutionizing structural biology by developing analytical tools that identify previously undetectable structural changes in biomolecules. Fluent Biosciences is making single-cell sequencing more efficient and accessible, enabling a deeper understanding of complex biological processes. Walking Fish is advancing cell-based therapeutics by engineering B-cells to produce therapeutic proteins, bringing hope to patients with genetic protein deficiencies, cancer, and infectious diseases.

Arbor is dedicated to the development of novel gene editing techniques, providing life-changing therapies for severe genetic diseases. With their commitment to propelling innovation and their impressive portfolio of game-changers, Illumina Ventures is shaping the future of genomics and precision health